Carry on.

COVID-19 led to a halt in many routine medical procedures and therapeutics. A conundrum in cancer care is that its felt to place patients at increased risk of severe COVID-19 while ongoing treatment can be key to cancer survival.  This single-institution analysis found that the receipt of cytotoxic chemotherapy was not associated with an increased risk of developing severe COVID-19. However, associations were complex and factors such as hematologic or lung malignancy, lymphopenia, and neutropenia were associated with worse COVID-19 outcomes. | Lee, J Clin Oncol 2020

Comments

  1. Hi there to everybody, it’s my first go to see of this web site; this weblog consists of awesome and in fact good stuff for visitors. Hurrah, that’s what I was exploring for, what stuff! Existing here at this blog, thanks admin of this web site. You can also visit Medicare Online Registration for more PPMP related information and knowledge.

    ReplyDelete
  2. Your blog is awfully appealing. I am contented with your post. I regularly read your blog and its very helpful. If you are looking for the best EC Representative, then visit I3CGLOBAL. Thanks! I enjoyed this blog post.

    ReplyDelete

Post a Comment

Popular Posts